Use of clot-busting drug for stroke has almost doubled

08/26/2013 | HealthDay News

An analysis of information from almost 1,700 U.S. hospitals found an increase in the use of clot-busting tissue plasminogen activator as a therapy for ischemic stroke, according to a study in the journal Circulation: Cardiovascular Quality and Outcomes. Among patients who were transported to hospitals swiftly and who did not have conditions that could increase the drug's risks, usage grew from 43% in 2003 to 77% in 2011. "We should be providing intravenous tPA to all eligible patients, which means that nearly a quarter of them are still missing that opportunity," researcher Dr. Lee Schwamm said.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA